Compare LABT & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LABT | MI |
|---|---|---|
| Founded | 2006 | 2009 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 670.6K | 546.6K |
| IPO Year | 2026 | 2022 |
| Metric | LABT | MI |
|---|---|---|
| Price | $0.20 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 607.7K | ★ 9.7M |
| Earning Date | 11-18-2026 | 12-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.18 |
| 52 Week High | $6.85 | $19.84 |
| Indicator | LABT | MI |
|---|---|---|
| Relative Strength Index (RSI) | 16.87 | 40.14 |
| Support Level | N/A | $0.22 |
| Resistance Level | $2.13 | $4.59 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 1.52 | 0.11 |
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.